ClinicalTrials.Veeva

Menu

Fluoride in Saliva After Use of Fluoride Toothpastes Followed by Fluoride Mouthrinses

University of Michigan logo

University of Michigan

Status and phase

Completed
Early Phase 1

Conditions

Dental Caries

Treatments

Drug: Colgate PreviDent 5000+ toothpaste followed by Act Mint Fluoride Rinse
Drug: Crest Cavity Protection toothpaste followed by Act Mint Fluoride Rinse
Drug: Colgate PreviDent 5000+ toothpaste
Drug: Crest Cavity Protection toothpaste

Study type

Interventional

Funder types

Other

Identifiers

NCT05601154
HUM00212598

Details and patient eligibility

About

This study will evaluate fluoride (F) bioavailability in saliva when using an over-the-counter mouthrinse of 226 ppm F, immediately after brushing with an over-the-counter toothpaste of 1,100 ppm F or a prescription toothpaste of 5,000 ppm F. The study population will include twenty individuals, over the age of 18 years-old, from both genders, with normal oral health conditions and salivary flow rate, no need of urgent dental needs, from the Ann Arbor, MI area. Participants will be recruited from the University of Michigan School of Dentistry, in Ann Arbor, MI. Using a crossover design, twenty participants will be rotating through 4 different combinations of fluoride toothpaste (over-the-counter or prescription concentration) and fluoride mouth rinse (yes or no), in a 2 x 2 factorial design. Treatments to be tested will be as followed: Group #1 will brush with 1,100 ppm F (over-the-counter) toothpaste; Group #2 will brush with 1,100 ppm F (over-the-counter) toothpaste and rinse with over-the-counter 226 ppm F mouthrinse; Group #3 will brush with 5,000 ppm F (prescription) toothpaste; Group #4 will brush with 5,000 ppm F (prescription) toothpaste and rinse with over-the-counter 226 ppm F mouthrinse.

Enrollment

20 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Sign informed consent form
  • Participant understands and agrees to comply with the study protocol, and confirms availability for the entire duration of the study
  • 18 years of age or older
  • Good general health
  • Good oral health, with no urgent treatment needs
  • Normal salivary flow rate

Exclusion criteria

  • Fail to understand or to agree to follow the study protocol
  • Reduced salivary flow rate
  • Poor general or oral health conditions

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

20 participants in 4 patient groups

Crest Cavity Protection
Active Comparator group
Description:
Crest Cavity Protection toothpaste (1,100 ppm F) will be used to brush teeth, followed by a mouth rinse with tap water
Treatment:
Drug: Crest Cavity Protection toothpaste
Crest Cavity Protection followed by Act Mint Fluoride Rinse
Active Comparator group
Description:
Crest Cavity Protection toothpaste (1,100 ppm F) will be used to brush teeth, followed by a mouth rinse with Act Mint Fluoride Rinse (226 ppm)
Treatment:
Drug: Crest Cavity Protection toothpaste followed by Act Mint Fluoride Rinse
Colgate PreviDent 5000+
Active Comparator group
Description:
Colgate PreviDent 5000+ (5,000 ppm F) will be used to brush teeth, followed by a mouth rinse with tap water
Treatment:
Drug: Colgate PreviDent 5000+ toothpaste
Colgate PreviDent 5000+ followed by Act Mint Fluoride Rinse
Experimental group
Description:
Colgate PreviDent 5000+ (5,000 ppm F) will be used to brush teeth, followed by a mouth rinse with Act Mint Fluoride Rinse (226 ppm)
Treatment:
Drug: Colgate PreviDent 5000+ toothpaste followed by Act Mint Fluoride Rinse

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems